James A. Bianco, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 40,000 shares at $2.54 ($102K) on 2014-08-15, disclosed to the SEC on 2014-08-15.
Scheduled sale ($102k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTIC | SELL | 2016-04-29 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-30 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-23 | $350K | — | Filing → |